Stock Analysis

McKesson Third Quarter 2025 Earnings: EPS Misses Expectations

NYSE:MCK
Source: Shutterstock

McKesson (NYSE:MCK) Third Quarter 2025 Results

Key Financial Results

  • Revenue: US$95.3b (up 18% from 3Q 2024).
  • Net income: US$879.0m (up 49% from 3Q 2024).
  • Profit margin: 0.9% (up from 0.7% in 3Q 2024).
  • EPS: US$6.98 (up from US$4.45 in 3Q 2024).
earnings-and-revenue-growth
NYSE:MCK Earnings and Revenue Growth February 10th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

McKesson EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 4.8%.

Looking ahead, revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 7.1% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for McKesson (1 shouldn't be ignored!) that you need to take into consideration.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:MCK

McKesson

Provides healthcare services in the United States and internationally.

Good value with limited growth.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|44.027% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|61.937% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|70.392% undervalued
StockMan
StockMan
Community Contributor